Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Renovaro Inc. - Common Stock (NQ: RENB )

0.8089 +0.0669 (+9.02%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Renovaro Inc. - Common Stock

< Previous 1 2 3 4 5 Next >
ROSEN, A LEADING NATIONAL FIRM, Encourages Renovaro Biosciences Inc. Investors to Inquire About Securities Class Action Investigation – RENB
From The Rosen Law Firm, P.A.
Via Business Wire
Why IPG Photonics Shares Are Trading Lower By Around 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Shares of IPG Photonics Corporation (NASDAQ: IPGP) fell sharply during Tuesday’s session after the company reported mixed fourth-quarter financial results and issued soft first-quarter guidance. 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Renovaro Biosciences Faces Turmoil After Hindenburg Report Accusing Questionable Merger And Governance, Stock Crashes
Renovaro Biosciences navigates challenges – from a controversial merger with GEDi Cube to allegations of securities law violations. 
Via Benzinga
Cutting Edge AI Company GEDiCube and Cyclomics sign binding LOI to join forces and position themselves at the forefront of the global liquid biopsy marketplace
From Renovaro Biosciences Inc.
Via GlobeNewswire
AI Pioneer GEDi Cube and Biotech Innovator Renovaro Biosciences Combine Forces to Accelerate Personalized Medicine
From Renovaro Biosciences Inc.
Via GlobeNewswire
Patients with Swelling Disorder See New Gene Therapy as Godsend
Via Investor Brand Network
Study Explains Why Immunotherapy Could Trigger Colitis in Cancer Patients
Via Investor Brand Network
BioMedNewsBreaks – Renovaro BioSciences Inc. (NASDAQ: RENB) Announces Results of Special Meeting
Via Investor Brand Network
Renovaro Biosciences Announces Results of Special Meeting of Shareholders
From Renovaro Biosciences Inc.
Via GlobeNewswire
BioMedNewsBreaks — Renovaro BioSciences Inc. (NASDAQ: RENB) Releases CEO Shareholder Message
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence
Message from Renovaro Bioscience, Inc.’s CEO, The Hon. Mark Dybul, MD
Accelerating Healthcare With Award-Winning AI: Big Steps Forward In 2023 And The Early Days Of 2024 
From Renovaro Biosciences Inc.
Via GlobeNewswire
Fruit Fly Study Opens Door to Novel Immunotherapy Approach Against Cancer
Via Investor Brand Network
RENOVARO BIOSCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Renovaro Biosciences Inc. - RENB
From Kahn Swick & Foti, LLC
Via Business Wire
Study Shows Ongoing Benefits Once Immunotherapy Stops
Via Investor Brand Network
Oncologist Explores Whether Including Fiber in Diets Boosts Immunotherapy Outcomes
Via Investor Brand Network
Researchers Harnessing Immune System to Fight Cancer More Effectively
Via Investor Brand Network
Study Says Patients on Gene Therapy Need Long-Term Monitoring
Via Investor Brand Network
BioMedNewsBreaks — Renovaro BioSciences Inc. (NASDAQ: RENB) CEO Featured Guest in Recent Proactive Interview
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence
BioMedNewsBreaks – Renovaro BioSciences Inc. (NASDAQ: RENB) Poised to Spearhead Advancements in Battle Against Diseases, Harness Cutting-Edge AI Technology
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence
BioMedNewsBreaks – Renovaro BioSciences Inc. (NASDAQ: RENB) Eyes Opportunity in Largely Untapped Precision Medicine Market
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence
Unlocking AI investment opportunities in healthcare
AI is revolutionizing healthcare by improving diagnosis and accelerating drug discovery. An often-overlooked sector with a wealth of AI opportunities. 
Via MarketBeat
Topics Artificial Intelligence ETFs
Exposures Artificial Intelligence
How Immunotherapy Is Cementing a Role in Cancer Treatment
Via Investor Brand Network
Renovaro Biosciences Inc. (NASDAQ: RENB) CEO Provides Update on Combination with AI Expert GEDiCube Intl Ltd. in Letter to Shareholders
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence
BioMedNewsBreaks — Renovaro BioSciences Inc. (NASDAQ: RENB), GEDi Cube Combine to Transform Medicine Through AI and Biotherapeutics
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence
Renovaro Biosciences Inc. (NASDAQ: RENB) Announces Three New Members to Board of Directors as Definitive Agreement with GEDiCube Announced
Via Investor Brand Network
Topics Artificial Intelligence Derivatives
Exposures Artificial Intelligence Derivatives
Alarming Data Highlights Gaps in Treating People with Chronic HBV
Via Investor Brand Network
Biotech Firms Register Successes in Quest for Better Pancreatic Cancer Treatments
Via Investor Brand Network
Renovaro BioSciences Inc. (NASDAQ: RENB) CEO Provides Insights on Definitive Agreement to Combine with GEDi Cube to Transform Medicine
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence
Scientists Find Potential to Reverse Prostate Cancer Treatment Resistance
Via Investor Brand Network
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.